GamaMabs Pharma

GamaMabs Pharma

GamaMabs Pharma

GamaMabs Pharmais a biotechnology firm engaged in the development of a new therapeutic antibody for the treatment of ovarian cancer.
Founded
2013
Raised
$21.8M
Follow us
Alexa global traffic share
Latest funding
$3,988,460
Venture capital - 2013
Team Size
2
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when GamaMabs Pharma makes some noise.